School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Martin Moore

  • Department of Pediatrics
    Adjunct Associate Professor
  • (404) 727-9162
  • mlmoor2@emory.edu
Head shot of Martin Moore

Academic Appointment

  • Assistant Professor, Department of Pediatrics, Division of Infectious Diseases, Emory University School of Medicine

Education

Degrees

  • PhD from University of Georgia
  • BS from University of Georgia

Research

Publications

  • Assembly of respiratory syncytial virus matrix protein lattice and its coordination with fusion glycoprotein trimers.
    Nat Commun Volume: 15 Page(s): 5923
    07/14/2024 Authors: Sibert BS; Kim JY; Yang JE; Ke Z; Stobart CC; Moore ML; Wright ER
  • An RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c Mice.
    J Infect Dis Volume: 227 Page(s): 50 - 60
    12/28/2022 Authors: Roe MK; Perez MA; Hsiao H-M; Lapp SA; Sun H-Y; Jadhao S; Young AR; Batista YS; Reed RC; Taz A
  • Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2.
    NPJ Vaccines Volume: 7 Page(s): 85
    07/29/2022 Authors: Tioni MF; Jordan R; Pena AS; Garg A; Wu D; Phan SI; Weiss CM; Cheng X; Greenhouse J; Orekov T
  • The Design of Vaccines Based on the Shielding of Antigenic Site of a Respiratory Syncytial Virus Fusion Protein Immunogen.
    Adv Healthc Mater Volume: 10 Page(s): e2000714
    02/01/2021 Authors: Frey SJ; Varner C; Arsiwala A; Currier MG; Moore ML; Kane RS
  • A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion.
    J Virol Volume: 95
    12/22/2020 Authors: Human S; Hotard AL; Rostad CA; Lee S; McCormick L; Larkin EK; Peret TCT; Jorba J; Lanzone J; Gebretsadik T
  • Antigenicity and immunogenicity of unique prefusion-mimic F proteins presented on enveloped virus-like particles.
    Vaccine Volume: 37 Page(s): 6656 - 6664
    10/16/2019 Authors: Kwon Y-M; Lee Y; Kim KH; Jung YJ; Li Z; Jeeva S; Lee S; Moore ML; Kang S-M
  • Evaluation of the role of respiratory syncytial virus surface glycoproteins F and G on viral stability and replication: implications for future vaccine design.
    J Gen Virol Volume: 100 Page(s): 1112 - 1122
    07/01/2019 Authors: DeFord DM; Nosek JM; Castiglia KR; Hasik EF; Franke ME; Nick BC; Abdelnour AM; Haas CE; Junod NA; Latsko KN
  • Respiratory Syncytial Virus Fusion Protein-encoding DNA Vaccine Is Less Effective in Conferring Protection against Inflammatory Disease than a Virus-like Particle Platform.
    Immune Netw Volume: 19 Page(s): e18
    06/01/2019 Authors: Kwon Y-M; Hwang HS; Lee Y-T; Kim K-H; Lee Y; Kim M-C; Lee Y-N; Quan F-S; Moore ML; Kang S-M
  • Nasopharyngeal Lactobacillus is associated with a reduced risk of childhood wheezing illnesses following acute respiratory syncytial virus infection in infancy.
    J Allergy Clin Immunol Volume: 142 Page(s): 1447 - 1456.e9
    11/01/2018 Authors: Rosas-Salazar C; Shilts MH; Tovchigrechko A; Schobel S; Chappell JD; Larkin EK; Gebretsadik T; Halpin RA; Nelson KE; Moore ML
  • Infant Viral Respiratory Infection Nasal Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent Wheeze.
    Am J Respir Crit Care Med Volume: 198 Page(s): 1064 - 1073
    10/15/2018 Authors: Turi KN; Shankar J; Anderson LJ; Rajan D; Gaston K; Gebretsadik T; Das SR; Stone C; Larkin EK; Rosas-Salazar C
  • Using urine metabolomics to understand the pathogenesis of infant respiratory syncytial virus (RSV) infection and its role in childhood wheezing.
    Metabolomics Volume: 14 Page(s): 135
    10/01/2018 Authors: Turi KN; Romick-Rosendale L; Gebretsadik T; Watanabe M; Brunwasser S; Anderson LJ; Moore ML; Larkin EK; Peebles RS; Hartert TV
  • The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron Tomography.
    Viruses Volume: 10
    08/20/2018 Authors: Ke Z; Dillard RS; Chirkova T; Leon F; Stobart CC; Hampton CM; Strauss JD; Rajan D; Rostad CA; Taylor JV
  • Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses.
    Antimicrob Agents Chemother Volume: 62
    08/01/2018 Authors: Yoon J-J; Toots M; Lee S; Lee M-E; Ludeke B; Luczo JM; Ganti K; Cox RM; Sticher ZM; Edpuganti V
  • Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology.
    J Allergy Clin Immunol Volume: 142 Page(s): 683 - 687.e12
    08/01/2018 Authors: Bloodworth MH; Rusznak M; Pfister CC; Zhang J; Bastarache L; Calvillo SA; Chappell JD; Boyd KL; Toki S; Newcomb DC
  • Generating Neutralizing Antibody responses using Recombinant Infectious Rhinovirus
    Volume: 200
    05/01/2018 Authors: Lee S; Tang R; Currier M; Moore M
  • Polyvalent vaccines: High-maintenance heroes.
    PLoS Pathog Volume: 14 Page(s): e1006904
    04/01/2018 Authors: Schlingmann B; Castiglia KR; Stobart CC; Moore ML
  • Enhancing the Thermostability and Immunogenicity of a Respiratory Syncytial Virus (RSV) Live-Attenuated Vaccine by Incorporating Unique RSV Line19F Protein Residues.
    J Virol Volume: 92
    03/15/2018 Authors: Rostad CA; Stobart CC; Todd SO; Molina SA; Lee S; Blanco JCG; Moore ML
  • Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins.
    PLoS Pathog Volume: 14 Page(s): e1006837
    02/01/2018 Authors: Mousa JJ; Binshtein E; Human S; Fong RH; Alvarado G; Doranz BJ; Moore ML; Ohi MD; Crowe JE
  • Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein.
    Nat Commun Volume: 8 Page(s): 1877
    11/30/2017 Authors: Tian D; Battles MB; Moin SM; Chen M; Modjarrad K; Kumar A; Kanekiyo M; Graepel KW; Taher NM; Hotard AL
  • STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral Infection.
    J Immunol Volume: 199 Page(s): 510 - 519
    07/15/2017 Authors: Stier MT; Goleniewska K; Cephus JY; Newcomb DC; Sherrill TP; Boyd KL; Bloodworth MH; Moore ML; Chen K; Kolls JK
  • Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion Protein.
    J Virol Volume: 91
    07/15/2017 Authors: Leemans A; De Schryver M; Van der Gucht W; Heykers A; Pintelon I; Hotard AL; Moore ML; Melero JA; McLellan JS; Graham BS
  • Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses.
    Nat Microbiol Volume: 2 Page(s): 17101
    06/30/2017 Authors: Chatterjee S; Luthra P; Esaulova E; Agapov E; Yen BC; Borek DM; Edwards MR; Mittal A; Jordan DS; Ramanan P
  • Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective.
    J Virol Volume: 91
    05/15/2017 Authors: Boyoglu-Barnum S; Todd SO; Meng J; Barnum TR; Chirkova T; Haynes LM; Jadhao SJ; Tripp RA; Oomens AG; Moore ML
  • Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.
    Hum Vaccin Immunother Volume: 13 Page(s): 1031 - 1039
    05/04/2017 Authors: Hwang HS; Kim K-H; Lee Y; Lee Y-T; Ko E-J; Park S; Lee JS; Lee B-C; Kwon Y-M; Moore ML
  • Interference Between Respiratory Syncytial Virus and Human Rhinovirus Infection in Infancy.
    J Infect Dis Volume: 215 Page(s): 1102 - 1106
    04/01/2017 Authors: Achten NB; Wu P; Bont L; Blanken MO; Gebretsadik T; Chappell JD; Wang L; Yu C; Larkin EK; Carroll KN
  • Glucagon-like peptide-1 receptor signaling attenuates RSV-induced type 2 responses and immunopathology
    Volume: 139 Page(s): AB270 - AB270
    02/01/2017 Authors: Peebles S; Bloodworth MH; Zhang J; Hotard A; Moore ML; Hartert TV; Niswender KD
  • Immunogenicity of 50-Valent Rhinovirus Vaccine
    Volume: 139 Page(s): AB376 - AB376
    02/01/2017 Authors: Lee S; Nguyen MT; Currier MG; Jenkins JB; Strobert EA; Kajon AE; Madan-Lala R; Bochkov YA; Gern JE; Roy K
  • Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
    Vaccine Volume: 35 Page(s): 694 - 702
    01/23/2017 Authors: Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
  • BAC-Based Recovery of Recombinant Respiratory Syncytial Virus (RSV).
    Methods Mol Biol Volume: 1602 Page(s): 111 - 124
    01/01/2017 Authors: Stobart CC; Hotard AL; Meng J; Moore ML
  • Loss Of Cftr Alters Alveolar Macrophage Viral Defense
    Volume: 195
    01/01/2017 Authors: Gauthier TW; Ping X; Anderson LJ; Moore ML; Brown L
  • Risk Or Protective Factor? Mild Respiratory Syncytial Virus Infection In Infancy And The Development Of Recurrent Childhood Wheeze
    Volume: 195
    01/01/2017 Authors: Rosas-Salazar C; Gebretsadik T; Anderson LJ; Jadhao S; Chappell JD; Larkin EK; Moore ML; Peebles RS; Hartert T
  • Interference Between Respiratory Syncytial Virus And Human Rhinovirus Infection In Infancy
    Volume: 195
    01/01/2017 Authors: Achten N; Wu P; Bont L; Gebretsadik T; Blanken M; Chappell JD; Wang L; Yu C; Larkin EK; Carroll KN
  • The Role Of Oxidative Stress In The Pathogenesis Of Recurrent Wheeze In Children Following Infant Viral Respiratory Illnesses
    Volume: 195
    01/01/2017 Authors: Rosas-Salazar C; Gebretsadik T; Milne GL; Turi KN; Anderson LJ; Chappell JD; Larkin EK; Moore ML; Peebles RS; Hartert T
  • Early-Life Nasopharyngeal Colonization With Lactobacillus Reduces Risk Of Childhood Wheezing Illnesses Following Respiratory Syncytial Virus Infection In Infancy
    Volume: 195
    01/01/2017 Authors: Rosas-Salazar C; Shilts M; Tovchigrechko A; Schobel S; Chappell JD; Larkin EK; Gebretsadik T; Halpin R; Nelson KE; Moore ML
  • Rhinovirus Biology, Antigenic Diversity, and Advancements in the Design of a Human Rhinovirus Vaccine.
    Front Microbiol Volume: 8 Page(s): 2412
    01/01/2017 Authors: Stobart CC; Nosek JM; Moore ML
  • A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation.
    Nat Commun Volume: 7 Page(s): 13916
    12/21/2016 Authors: Stobart CC; Rostad CA; Ke Z; Dillard RS; Hampton CM; Strauss JD; Yi H; Hotard AL; Meng J; Pickles RJ
  • Differences in the Nasopharyngeal Microbiome During Acute Respiratory Tract Infection With Human Rhinovirus and Respiratory Syncytial Virus in Infancy.
    J Infect Dis Volume: 214 Page(s): 1924 - 1928
    12/15/2016 Authors: Rosas-Salazar C; Shilts MH; Tovchigrechko A; Schobel S; Chappell JD; Larkin EK; Shankar J; Yooseph S; Nelson KE; Halpin RA
  • A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques.
    Nat Commun Volume: 7 Page(s): 12838
    09/22/2016 Authors: Lee S; Nguyen MT; Currier MG; Jenkins JB; Strobert EA; Kajon AE; Madan-Lala R; Bochkov YA; Gern JE; Roy K
  • Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin.
    J Allergy Clin Immunol Volume: 138 Page(s): 814 - 824.e11
    09/01/2016 Authors: Stier MT; Bloodworth MH; Toki S; Newcomb DC; Goleniewska K; Boyd KL; Quitalig M; Hotard AL; Moore ML; Hartert TV
  • A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats.
    J Virol Volume: 90 Page(s): 7508 - 7518
    08/15/2016 Authors: Rostad CA; Stobart CC; Gilbert BE; Pickles RJ; Hotard AL; Meng J; Blanco JCG; Moin SM; Graham BS; Piedra PA
  • Fluorescent and Bioluminescent Reporter Myxoviruses.
    Viruses Volume: 8
    08/04/2016 Authors: Rostad CA; Currier MC; Moore ML
  • Respiratory Syncytial Virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G gene.
    Sci Rep Volume: 6 Page(s): 26311
    05/23/2016 Authors: Schobel SA; Stucker KM; Moore ML; Anderson LJ; Larkin EK; Shankar J; Bera J; Puri V; Shilts MH; Rosas-Salazar C
  • Nasopharyngeal Microbiome in Respiratory Syncytial Virus Resembles Profile Associated with Increased Childhood Asthma Risk.
    Am J Respir Crit Care Med Volume: 193 Page(s): 1180 - 1183
    05/15/2016 Authors: Rosas-Salazar C; Shilts MH; Tovchigrechko A; Chappell JD; Larkin EK; Nelson KE; Moore ML; Anderson LJ; Das SR; Hartert TV
  • EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression.
    PLoS Pathog Volume: 12 Page(s): e1005622
    05/01/2016 Authors: Currier MG; Lee S; Stobart CC; Hotard AL; Villenave R; Meng J; Pretto CD; Shields MD; Nguyen MT; Todd SO
  • TSLP Neutralization Inhibits ILC2 Activation Induced By Multiple Pathogenic Clinical Isolates of RSV
    Volume: 137 Page(s): AB90 - AB90
    02/01/2016 Authors: Stier MT; Toki S; Newcomb DC; Bloodworth MH; Hartert TV; Moore ML; Peebles RS
  • Priming of the Respiratory Tract with Immunobiotic Lactobacillus plantarum Limits Infection of Alveolar Macrophages with Recombinant Pneumonia Virus of Mice (rK2-PVM).
    J Virol Volume: 90 Page(s): 979 - 991
    01/15/2016 Authors: Dyer KD; Drummond RA; Rice TA; Percopo CM; Brenner TA; Barisas DAG; Karpe KA; Moore ML; Rosenberg HF
  • Metabolomics Approach To Understanding The Pathogenesis Of Respiratory Syncytial Virus (rsv) Infection
    Volume: 193
    01/01/2016 Authors: Turi KN; Steinhoff M; Watanabe M; Romick-Rosendale L; Moore ML; Anderson LJ; Larkin EK; Gebretsadik T; Harter TV
  • The Nasopharyngeal Microbiome During Acute Rsv Infection Resembles The Bacterial Profile Associated With Increased Risk Of Childhood Asthma
    Volume: 193
    01/01/2016 Authors: Rosas-Salazar C; Shilts MH; Yooseph S; Chappell JD; Larkin EK; Halpin RA; Nelson KE; Moore ML; Anderson LJ; Peebles RS
  • Respiratory Syncytial Virus-Infected Mesenchymal Stem Cells Regulate Immunity via Interferon Beta and Indoleamine-2,3-Dioxygenase.
    PLoS One Volume: 11 Page(s): e0163709
    01/01/2016 Authors: Cheung MB; Sampayo-Escobar V; Green R; Moore ML; Mohapatra S; Mohapatra SS
  • Reverse Genetics of Respiratory Syncytial Virus.
    Methods Mol Biol Volume: 1442 Page(s): 141 - 153
    01/01/2016 Authors: Stobart CC; Hotard AL; Meng J; Moore ML
  • Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein.
    J Virol Volume: 90 Page(s): 245 - 253
    01/01/2016 Authors: Meng J; Hotard AL; Currier MG; Lee S; Stobart CC; Moore ML
  • Minimally Invasive Sampling Method Identifies Differences in Taxonomic Richness of Nasal Microbiomes in Young Infants Associated with Mode of Delivery.
    Microb Ecol Volume: 71 Page(s): 233 - 242
    01/01/2016 Authors: Shilts MH; Rosas-Salazar C; Tovchigrechko A; Larkin EK; Torralba M; Akopov A; Halpin R; Peebles RS; Moore ML; Anderson LJ
  • CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells.
    J Gen Virol Volume: 96 Page(s): 2543 - 2556
    09/01/2015 Authors: Chirkova T; Lin S; Oomens AGP; Gaston KA; Boyoglu-Barnum S; Meng J; Stobart CC; Cotton CU; Hartert TV; Moore ML
  • An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice.
    Virology Volume: 483 Page(s): 117 - 125
    09/01/2015 Authors: Boyoglu-Barnum S; Todd SO; Chirkova T; Barnum TR; Gaston KA; Haynes LM; Tripp RA; Moore ML; Anderson LJ
  • Functional Analysis of the 60-Nucleotide Duplication in the Respiratory Syncytial Virus Buenos Aires Strain Attachment Glycoprotein.
    J Virol Volume: 89 Page(s): 8258 - 8266
    08/01/2015 Authors: Hotard AL; Laikhter E; Brooks K; Hartert TV; Moore ML
  • RSV-Induced H3K4 Demethylase KDM5B Leads to Regulation of Dendritic Cell-Derived Innate Cytokines and Exacerbates Pathogenesis In Vivo.
    PLoS Pathog Volume: 11 Page(s): e1004978
    06/01/2015 Authors: Ptaschinski C; Mukherjee S; Moore ML; Albert M; Helin K; Kunkel SL; Lukacs NW
  • Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate.
    PLoS Pathog Volume: 11 Page(s): e1004995
    06/01/2015 Authors: Deval J; Hong J; Wang G; Taylor J; Smith LK; Fung A; Stevens SK; Liu H; Jin Z; Dyatkina N
  • Objectives, design and enrollment results from the Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE).
    BMC Pulm Med Volume: 15 Page(s): 45
    04/30/2015 Authors: Larkin EK; Gebretsadik T; Moore ML; Anderson LJ; Dupont WD; Chappell JD; Minton PA; Peebles RS; Moore PE; Valet RS
  • Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease.
    Antiviral Res Volume: 115 Page(s): 1 - 8
    03/01/2015 Authors: Lee Y-N; Hwang HS; Kim M-C; Lee Y-T; Lee JS; Moore ML; Kang S-M
  • Development of a Simple, Rapid Microneutralization Test for Respiratory Syncytial Virus Subgroup B
    Volume: 135 Page(s): AB103 - AB103
    02/01/2015 Authors: Teng M; Tran KC; Hotard AL; Moore ML
  • Respiratory Syncytial Virus Induces IL-13+Group 2 Innate Lymphoid Cells Via TSLP
    Volume: 135 Page(s): AB171 - AB171
    02/01/2015 Authors: Stier MT; Toki S; Goleniewska K; Moore ML; Peebles RS
  • Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells.
    Nanomedicine Volume: 11 Page(s): 99 - 108
    01/01/2015 Authors: Ko E-J; Kwon Y-M; Lee JS; Hwang HS; Yoo S-E; Lee Y-N; Lee Y-T; Kim M-C; Cho MK; Lee YR
  • Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis.
    J Virol Volume: 89 Page(s): 512 - 522
    01/01/2015 Authors: Hotard AL; Lee S; Currier MG; Crowe JE; Sakamoto K; Newcomb DC; Peebles RS; Plemper RK; Moore ML
  • Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma.
    Am J Respir Crit Care Med Volume: 191 Page(s): 34 - 44
    01/01/2015 Authors: Feldman AS; He Y; Moore ML; Hershenson MB; Hartert TV
  • Mammalian Cell-Derived Respiratory Syncytial Virus-Like Particles Protect the Lower as well as the Upper Respiratory Tract.
    PLoS One Volume: 10 Page(s): e0130755
    01/01/2015 Authors: Walpita P; Johns LM; Tandon R; Moore ML
  • Development of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genes.
    Expert Rev Vaccines Volume: 14 Page(s): 1563 - 1572
    01/01/2015 Authors: Stobart CC; Moore ML
  • Innate And Adaptive Immune Response To Infant Respiratory Syncytial Virus Infection And Respiratory Morbidity In Early Childhood
    Volume: 191
    01/01/2015 Authors: Rosas-Salazar C; Anderson LJ; Chappell JD; Gebretsadik T; Larkin EK; Moore ML; Peebles RS; Hartert TV
  • Interferon response and respiratory virus control are preserved in bronchial epithelial cells in asthma.
    J Allergy Clin Immunol Volume: 134 Page(s): 1402 - 1412.e7
    12/01/2014 Authors: Patel DA; You Y; Huang G; Byers DE; Kim HJ; Agapov E; Moore ML; Peebles RS; Castro M; Sumino K
  • Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins.
    Antiviral Res Volume: 111 Page(s): 129 - 135
    11/01/2014 Authors: Lee S; Quan F-S; Kwon Y; Sakamoto K; Kang S-M; Compans RW; Moore ML
  • Refining the balance of attenuation and immunogenicity of respiratory syncytial virus by targeted codon deoptimization of virulence genes.
    mBio Volume: 5 Page(s): e01704 - e01714
    09/23/2014 Authors: Meng J; Lee S; Hotard AL; Moore ML
  • Cyclooxygenase inhibition abrogates aeroallergen-induced immune tolerance by suppressing prostaglandin I2 receptor signaling.
    J Allergy Clin Immunol Volume: 134 Page(s): 698 - 705.e5
    09/01/2014 Authors: Zhou W; Goleniewska K; Zhang J; Dulek DE; Toki S; Lotz MT; Newcomb DC; Boswell MG; Polosukhin VV; Milne GL
  • Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice.
    J Virol Volume: 88 Page(s): 10569 - 10583
    09/01/2014 Authors: Boyoglu-Barnum S; Chirkova T; Todd SO; Barnum TR; Gaston KA; Jorquera P; Haynes LM; Tripp RA; Moore ML; Anderson LJ
  • Allergic airway inflammation decreases lung bacterial burden following acute Klebsiella pneumoniae infection in a neutrophil- and CCL8-dependent manner.
    Infect Immun Volume: 82 Page(s): 3723 - 3739
    09/01/2014 Authors: Dulek DE; Newcomb DC; Goleniewska K; Cephus J; Zhou W; Reiss S; Toki S; Ye F; Zaynagetdinov R; Sherrill TP
  • STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challenge.
    J Virol Volume: 88 Page(s): 9655 - 9672
    09/01/2014 Authors: Dulek DE; Newcomb DC; Toki S; Goliniewska K; Cephus J; Reiss S; Bates JT; Crowe JE; Boyd KL; Moore ML
  • Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors.
    Proc Natl Acad Sci U S A Volume: 111 Page(s): E3441 - E3449
    08/19/2014 Authors: Yan D; Lee S; Thakkar VD; Luo M; Moore ML; Plemper RK
  • RNA virus reverse genetics and vaccine design.
    Viruses Volume: 6 Page(s): 2531 - 2550
    06/25/2014 Authors: Stobart CC; Moore ML
  • Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease.
    Antiviral Res Volume: 104 Page(s): 1 - 6
    04/01/2014 Authors: Kwon Y-M; Hwang HS; Lee JS; Ko E-J; Yoo S-E; Kim M-C; Lee Y-N; Kim K-H; Song J-M; Lee S
  • An overview of respiratory syncytial virus.
    PLoS Pathog Volume: 10 Page(s): e1004016
    04/01/2014 Authors: Meng J; Stobart CC; Hotard AL; Moore ML
  • Epidermal Growth Factor Receptor (EGFR) Mediates Cell Fusion and Infectivity Of Respiratory Syncytial Virus (RSV)
    Volume: 133 Page(s): AB71 - AB71
    02/01/2014 Authors: Lee S; Currier MG; Hotard AL; Meng J; Pretto C; Power UF; Villenave R; Shields MD; Chi MH; Peebles RS
  • Targeting CD137 enhances vaccine-elicited anti-respiratory syncytial virus CD8+ T cell responses in aged mice.
    J Immunol Volume: 192 Page(s): 293 - 299
    01/01/2014 Authors: Lee S; Mittler RS; Moore ML
  • Respiratory syncytial virus (RSV) infection in elderly mice results in altered antiviral gene expression and enhanced pathology.
    PLoS One Volume: 9 Page(s): e88764
    01/01/2014 Authors: Wong TM; Boyapalle S; Sampayo V; Nguyen HD; Bedi R; Kamath SG; Moore ML; Mohapatra S; Mohapatra SS
  • The impact of viral genotype on pathogenesis and disease severity: respiratory syncytial virus and human rhinoviruses.
    Curr Opin Immunol Volume: 25 Page(s): 761 - 768
    12/01/2013 Authors: Moore ML; Stokes KL; Hartert TV
  • A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice.
    J Virol Volume: 87 Page(s): 10955 - 10967
    10/01/2013 Authors: Boyoglu-Barnum S; Gaston KA; Todd SO; Boyoglu C; Chirkova T; Barnum TR; Jorquera P; Haynes LM; Tripp RA; Moore ML
  • Dual myxovirus screen identifies a small-molecule agonist of the host antiviral response.
    J Virol Volume: 87 Page(s): 11076 - 11087
    10/01/2013 Authors: Yan D; Krumm SA; Sun A; Steinhauer DA; Luo M; Moore ML; Plemper RK
  • The respiratory syncytial virus fusion protein targets to the perimeter of inclusion bodies and facilitates filament formation by a cytoplasmic tail-dependent mechanism.
    J Virol Volume: 87 Page(s): 10730 - 10741
    10/01/2013 Authors: Baviskar PS; Hotard AL; Moore ML; Oomens AGP
  • The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection.
    J Virol Volume: 87 Page(s): 10070 - 10082
    09/01/2013 Authors: Stokes KL; Currier MG; Sakamoto K; Lee S; Collins PL; Plemper RK; Moore ML
  • Phosphatidylglycerol provides short-term prophylaxis against respiratory syncytial virus infection.
    J Lipid Res Volume: 54 Page(s): 2133 - 2143
    08/01/2013 Authors: Numata M; Nagashima Y; Moore ML; Berry KZ; Chan M; Kandasamy P; Peebles RS; Murphy RC; Voelker DR
  • Respiratory syncytial virus infection of infant mice disables regulatory T cells with loss of protection from allergic airway disease
    Volume: 190
    05/01/2013 Authors: Krishnamoorthy N; Khare A; Oriss T; Raundhal M; Morse C; Moore M; Peebles RS; Ray A; Ray P
  • Enhancement of vaccine-induced respiratory syncytial virus-specific memory CD8 T cell responses by targeting 41BB
    Volume: 190
    05/01/2013 Authors: Lee S; Moore M
  • Analysis of bronchoalveolar immune cells and cytokines induced by immunization with different respiratory syncytial virus vaccines
    Volume: 190
    05/01/2013 Authors: Ko E-J; Lee JS; Lee Y-N; Kwon Y-M; Hwang HS; Yoo S-E; Quan F-S; Lee S; Moore M; Kang S-M
  • Influence of respiratory syncytial virus strain differences on pathogenesis and immunity.
    Volume: 372 Page(s): 59 - 82
    01/01/2013 Authors: Melero JA; Moore ML
  • Preservation Of Interferon Response And Viral Control In Bronchial Epithelial Cells In Asthma
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE Volume: 187
    01/01/2013 Authors: Patel DA; Huang G; You Y; Kim H; Byers DE; Moore ML; Peebles RS; Castro M; Holtzman MJ
  • Respiratory syncytial virus and reactive airway disease.
    Curr Top Microbiol Immunol Volume: 372 Page(s): 105 - 118
    01/01/2013 Authors: Lotz MT; Moore ML; Peebles RS
  • A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis.
    Virology Volume: 434 Page(s): 129 - 136
    12/05/2012 Authors: Hotard AL; Shaikh FY; Lee S; Yan D; Teng MN; Plemper RK; Crowe JE; Moore ML
  • Vaccine-elicited CD8+ T cells protect against respiratory syncytial virus strain A2-line19F-induced pathogenesis in BALB/c mice.
    J Virol Volume: 86 Page(s): 13016 - 13024
    12/01/2012 Authors: Lee S; Stokes KL; Currier MG; Sakamoto K; Lukacs NW; Celis E; Moore ML
  • An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice.
    Immun Ageing Volume: 9 Page(s): 21
    10/02/2012 Authors: Cherukuri A; Stokes KL; Patton K; Kuo H; Sakamoto K; Lambert S; Stillman E; Moore ML; Lee S
  • Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma.
    Nat Med Volume: 18 Page(s): 1525 - 1530
    10/01/2012 Authors: Krishnamoorthy N; Khare A; Oriss TB; Raundhal M; Morse C; Yarlagadda M; Wenzel SE; Moore ML; Peebles RS; Ray A
  • Vaccine-elicited CD8+T cells protect against respiratory syncytial virus-induced lung airway obstruction
    Volume: 188
    05/01/2012 Authors: Lee S; Stokes K; Celis E; Moore M
  • Examining the Role of Neutrophils in Respiratory Syncytial Virus (RSV) Infection
    Volume: 188
    05/01/2012 Authors: Stokes K; Moore M
  • Repression of the H3K4 demethylase Jarid1b leads to activation of RSV-infected dendritic cells
    Volume: 188
    05/01/2012 Authors: Ptaschinski C; Mukherjee S; Petersen B; Moore M; Kunkel S; Lukacs N
  • Independent structural domains in paramyxovirus polymerase protein.
    J Biol Chem Volume: 287 Page(s): 6878 - 6891
    02/24/2012 Authors: Dochow M; Krumm SA; Crowe JE; Moore ML; Plemper RK
  • A critical phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly of internal viral proteins into viral filaments and particles.
    mBio Volume: 3
    01/01/2012 Authors: Shaikh FY; Cox RG; Lifland AW; Hotard AL; Williams JV; Moore ML; Santangelo PJ; Crowe JE
  • Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice.
    J Infect Dis Volume: 204 Page(s): 987 - 995
    10/01/2011 Authors: Quan F-S; Kim Y; Lee S; Yi H; Kang S-M; Bozja J; Moore ML; Compans RW
  • Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice.
    J Virol Volume: 85 Page(s): 5782 - 5793
    06/01/2011 Authors: Stokes KL; Chi MH; Sakamoto K; Newcomb DC; Currier MG; Huckabee MM; Lee S; Goleniewska K; Pretto C; Williams JV
  • Treatment with Anti-CD137 (41BB) mAb enhances peptide vaccination against respiratory syncytial virus in aged mice
    JOURNAL OF IMMUNOLOGY Volume: 186
    04/01/2011 Authors: Lee S; Mittler R; Moore M
  • BALB/c mouse model of RSV clinical isolate A2001/2-20 pathogenesis
    JOURNAL OF IMMUNOLOGY Volume: 186
    04/01/2011 Authors: Stokes K; Chi M; Sakamoto K; Newcomb D; Huckabee M; Lee S; Pretto C; Williams J; Peebles R; Moore M
  • Impact of pollution, climate, and sociodemographic factors on spatiotemporal dynamics of seasonal respiratory viruses.
    Clin Transl Sci Volume: 4 Page(s): 48 - 54
    02/01/2011 Authors: Sloan C; Moore ML; Hartert T
  • RSV AND THE LUNG EXPOSED TO ETHANOL IN UTERO
    Volume: 34 Page(s): 300A - 300A
    06/01/2010 Authors: Gauthier TW; Moore M; Ping X-D; Harris FL; Brown LAS
  • B cell and peptide based immunotherapy vaccine for Respiratory Syncytial Virus (RSV) infection
    JOURNAL OF IMMUNOLOGY Volume: 184
    04/01/2010 Authors: Lee S; Currier M; Celis E; Moore M
  • RSV Strain 2-20 Induces More Severe Disease in BALB/c Mice than RSV Strain 3-12
    JOURNAL OF IMMUNOLOGY Volume: 184
    04/01/2010 Authors: Stokes K; Lee S; Chi M; Sturkie C; Peebles R; Moore M
  • STAT1 negatively regulates lung basophil IL-4 expression induced by respiratory syncytial virus infection.
    J Immunol Volume: 183 Page(s): 2016 - 2026
    08/01/2009 Authors: Moore ML; Newcomb DC; Parekh VV; Van Kaer L; Collins RD; Zhou W; Goleniewska K; Chi MH; Mitchell D; Boyce JA
  • A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction.
    J Virol Volume: 83 Page(s): 4185 - 4194
    05/01/2009 Authors: Moore ML; Chi MH; Luongo C; Lukacs NW; Polosukhin VV; Huckabee MM; Newcomb DC; Buchholz UJ; Crowe JE; Goleniewska K
  • A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production.
    J Immunol Volume: 182 Page(s): 5317 - 5321
    05/01/2009 Authors: Newcomb DC; Zhou W; Moore ML; Goleniewska K; Hershey GKK; Kolls JK; Peebles RS
  • STAT1 Negatively Regulates Basophil IL-4 Expression Induced by Respiratory Syncytial Vrus Infection and
    Volume: 123 Page(s): S153 - S153
    02/01/2009 Authors: Moore ML; Parekh VV; Van Kaer L; Collins RD; Goleniewska K; Chi MH; Mitchell D; Durbin JE; Peebles RS
  • PGE(2) And EP2 Receptor Signaling Suppress IL-17 Production By Polarized Mouse Th17 Cells
    Volume: 123 Page(s): S91 - S91
    02/01/2009 Authors: Zhou W; Newcomb DC; Goleniewska K; Moore ML; Peelbes RS
  • A Functional IL-13 Receptor is Expressed on Polarized Murine CD4+Th17 Cells and IL-13 Signaling Negatively Regulates Th17 Cytokine Production
    Volume: 123 Page(s): S138 - S138
    02/01/2009 Authors: Newcomb DC; Zhou W; Moore ML; Goleniewska K; Hershey GKK; Kolls JK; Peebles RS
  • Cyclooxygenase inhibition during allergic sensitization increases STAT6-independent primary and memory Th2 responses.
    J Immunol Volume: 181 Page(s): 5360 - 5367
    10/15/2008 Authors: Zhou W; Newcomb DC; Moore ML; Goleniewska K; O'Neal JF; Peebles RS
  • Differential regulation of GM1 and asialo-GM1 expression by T cells and natural killer (NK) cells in respiratory syncytial virus infection.
    Viral Immunol Volume: 21 Page(s): 327 - 339
    09/01/2008 Authors: Moore ML; Chi MH; Goleniewska K; Durbin JE; Peebles RS
  • Respiratory syncytial virus infections augment allergen specific T cell secretion of lung IL-17A
    Volume: 121 Page(s): S135 - S135
    02/01/2008 Authors: Newcomb DC; Moore ML; Goleniewska K; Zhou W; Peebles RS
  • A mechanistic advance in understanding RSV pathogenesis, but still a long way from therapy.
    Am J Respir Cell Mol Biol Volume: 37 Page(s): 375 - 377
    10/01/2007 Authors: Peebles RS; Moore ML
  • Cutting Edge: Oseltamivir decreases T cell GM1 expression and inhibits clearance of respiratory syncytial virus: potential role of endogenous sialidase in antiviral immunity.
    J Immunol Volume: 178 Page(s): 2651 - 2654
    03/01/2007 Authors: Moore ML; Chi MH; Zhou W; Goleniewska K; O'Neal JF; Higginbotham JN; Peebles RS
  • Natural killer (NK) cells, not T cells, produce the cytokine IL-4 in response to primary respiratory syncytial virus infection
    Volume: 119 Page(s): 523 - 523
    02/01/2007 Authors: Moore ML; Parekh VV; Van Kaer L; Collins RD; Goleniewska K; O'Neal JF; Chi MH; Durbin JE; Peebles RS
  • Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics.
    Pharmacol Ther Volume: 112 Page(s): 405 - 424
    11/01/2006 Authors: Moore ML; Peebles RS
  • Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus.
    Am J Pathol Volume: 169 Page(s): 977 - 986
    09/01/2006 Authors: Lukacs NW; Moore ML; Rudd BD; Berlin AA; Collins RD; Olson SJ; Ho SB; Peebles RS
  • Update on the role of prostaglandins in allergic lung inflammation: separating friends from foes, harder than you might think.
    J Allergy Clin Immunol Volume: 117 Page(s): 1036 - 1039
    05/01/2006 Authors: Moore ML; Peebles RS
  • Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependent
    Volume: 117 Page(s): S145 - S145
    02/01/2006 Authors: Peebles R; Hashimoto K; Sheller JR; Moore ML; Morrow JD; Ji S; Elias JA; Goleniewska K; O'Neall JF; Mitchell DB
  • Respiratory syncytial virus-induced airway dysfunction depends on the virus strain
    Volume: 117 Page(s): S206 - S206
    02/01/2006 Authors: Moore ML; Lukacs NW; Rudd BD; Polosukhin VV; Chi MH; Goleniewska K; O'Neal JF; Peebles RS
  • IL-13 is associated with reduced illness and replication in primary respiratory syncytial virus infection in the mouse.
    Microbes Infect Volume: 8 Page(s): 2880 - 2889
    01/01/2006 Authors: Zhou W; Hashimoto K; Moore ML; Elias JA; Zhu Z; Durbin J; Colasurdo G; Rutigliano JA; Chiappetta CL; Goleniewska K
  • Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependent.
    J Immunol Volume: 175 Page(s): 8253 - 8259
    12/15/2005 Authors: Peebles RS; Hashimoto K; Sheller JR; Moore ML; Morrow JD; Ji S; Elias JA; Goleniewska K; O'neal J; Mitchell DB
  • Fatal disseminated mouse adenovirus type 1 infection in mice lacking B cells or Bruton's tyrosine kinase.
    J Virol Volume: 78 Page(s): 5584 - 5590
    06/01/2004 Authors: Moore ML; McKissic EL; Brown CC; Wilkinson JE; Spindler KR
  • T cells cause acute immunopathology and are required for long-term survival in mouse adenovirus type 1-induced encephalomyelitis.
    J Virol Volume: 77 Page(s): 10060 - 10070
    09/01/2003 Authors: Moore ML; Brown CC; Spindler KR
  • SJL/J mice are highly susceptible to infection by mouse adenovirus type 1.
    J Virol Volume: 75 Page(s): 12039 - 12046
    12/01/2001 Authors: Spindler KR; Fang L; Moore ML; Hirsch GN; Brown CC; Kajon A
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements